Cook Jodi A 4
4 · FENNEC PHARMACEUTICALS INC. · Filed Jun 10, 2026
Research Summary
AI-generated summary of this filing
Fennec Pharmaceuticals Director Jodi Cook Receives Option Award
What Happened
Jodi A. Cook, a director of Fennec Pharmaceuticals, was granted a non‑qualified stock option to acquire 20,000 shares on June 10, 2026. The option strike price is $8.70 per share (20,000 × $8.70 = $174,000 reported value). This filing reports an award (derivative grant), not a purchase or sale of underlying shares.
Key Details
- Transaction date: 2026-06-10; transaction type: A (award/grant of derivative).
- Grant: 20,000 stock options with exercise price $8.70; reported aggregate value $174,000.
- Vesting: 100% vested on grant (per footnote). Options can be exercised immediately, but no exercise or sale is reported.
- Shares owned after transaction: Not specified in this filing.
- Timeliness: Filing dated 2026-06-10 (same date as transaction), so not indicated as late.
Context
A non‑qualified stock option is a compensation award that gives the holder the right to buy common shares at the stated strike ($8.70). Until exercised, the award is a derivative — it does not represent current share ownership or a market purchase. Grants are routine compensation for executives/directors and do not by themselves indicate buying/selling of stock.
Insider Transaction Report
- Award
Stock Options
[F1][F2]2026-06-10$8.70/sh+20,000$174,000→ 160,000 totalExercise: $8.70From: 2026-06-10Exp: 2036-06-10→ Common Shares (20,000 underlying)
Footnotes (2)
- [F1]On June 10, 2026, Jodi Cook was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.
- [F2]The option is 100% vested on date of grant.